NERVE BLOOD FLOW IN NORMAL AND ISCHEMIC PERIPHERAL NERVE
正常和缺血性周围神经的神经血流量
基本信息
- 批准号:3404597
- 负责人:
- 金额:$ 17.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1985
- 资助国家:美国
- 起止时间:1985-07-01 至 1995-06-30
- 项目状态:已结题
- 来源:
- 关键词:autoradiography axon biopsy calcium channel blockers capillary catalase catecholamines cholesterol corticosteroids denervation diabetic neuropathy disease /disorder model eicosanoids electrophysiology embolism free radicals human tissue ischemia laboratory rat microcirculation microelectrodes oxygen perfusion peripheral nervous system polarography reperfusion superoxide dismutase sympathetic nervous system tritium vasodilators
项目摘要
Nerve microvasculature is physiologically unique, being a poorly
autoregulating, nutritive-capacitance system of large capillaries
that is relatively resistant to ischemia. Yet angiopathic
neuropathies occur, are relatively common and are difficult to
treat. Nerve ischemia may also occur in disorders such as
diabetic , edematous and entrapment neuropathies. The broad
aim of this continuation proposal is an intensified focus on the
physiology of nerve ischemia. The specific aims, rationale, and
methods proposed are: First, a 3-dimensional reconstruction of
nerve blood flow (NBF) in ischemic models of neuropathy and in
response to sympathetic stimulation and denervation. Studies to
date on the physiology of nerve ischemia have been
unidimensional, focusing on nerve trunk and neglecting the much
more metabolically active cell body and at-risk distal axon. By
using combined microelectrode-H2-polarography and 14C-
iodoantipyrine autoradiography, it should be possible to determine
flow simultaneously at the cell body (dorsal root and sympathetic
ganglia) and the nerve fiber levels. Second, an evaluation of the
molecular mechanisms of nerve ischemic and reperfusion injury on
which information is totally lacking. The hypothesis that nerve is
damaged during ischemia and reperfusion due to an interplay of
oxygen free radicals (OFR) and eicosanoids will be tested. NBF,
computerized videoangiology, blood-nerve barrier (BNB; to 14C-
sucrose) and nerve electrophysiologic indices will be supplemented
by estimations of nerve cholesterol, arachidonic acid, fatty acid
profile, malondialdehyde (MDA) and superoxide dismutase (SOD)
as indices of OFR damage and the biosynthesis by nerve in situ
and in vitro of thromboxane B2 and 6-keto-PFG1 alpha will be
used as indices of nerve eiscosanoids and nerve catecholamines
will be measured. These studies will be done during ischemia and
following reperfusion. Third, an evaluation of mechanisms to
ameliorate the effects of ischemia and reperfusion. Calcium
channel blockers, vasodilator eiscosanoids, corticosteroids,
pentoxifylline and ketanserin may ameliorate microvascular
ischemia in other tissues, but their mechanisms and effectiveness
in peripheral nerve is unknown. Since the time-course of ischemic
fiber damage is very slow, occurring over many hours, nerve
comprises a system particularly suited for intervention therapy
should it become available. Finally, nerve catecholamines,
eicosanoids, MDA and SOD will be measured in sural nerve
biopsied for reasons unrelated to this proposal to apply some of
these techniques and strategies to humans.
神经微血管在生理上是独特的,是一种很差的
大毛细血管的自动调节、营养电容系统
对缺血有相对的抵抗力。然而,血管病变
神经性疾病会发生,是相对常见的,很难
请客。神经缺血也可能发生在以下疾病中
糖尿病、水肿性和嵌顿性神经病。《博大》
这项延续提案的目的是加强对
神经缺血生理学。具体的目标、理论基础和
提出的方法有:第一,三维重建
神经病和脑缺血模型的神经血流量(NBF)
对交感神经刺激和去神经的反应。研究到
关于神经缺血的生理学研究数据一直以来
一维的,专注于神经干而忽略了很多
新陈代谢更活跃的细胞体和危险的远端轴突。通过
用微电极-H_2极谱和~(14)C-极谱相结合的方法
碘安替比林放射自显影,应该可以确定
同时在细胞体(背根和交感神经)流动
神经节)和神经纤维水平。第二,对中国经济发展的评价
大鼠神经缺血再灌注损伤的分子机制
而这些信息是完全缺乏的。神经是一种假设
在缺血和再灌流期间由于相互作用而受损
将测试氧自由基(OFR)和二十烷类化合物。NBF,
计算机视频血管学,血-神经屏障(BNB;至14C-
补充蔗糖)和神经电生理指标
通过测定神经胆固醇、花生四烯酸、脂肪酸
丙二醛(MDA)和超氧化物歧化酶(SOD)
作为氧自由基损伤和神经原位生物合成的指标
而在体外血栓烷B2和6-酮-PFG1α将
用作神经儿茶酚胺和神经儿茶酚胺的指标
将会被测量。这些研究将在缺血期和
再灌流后。第三,评估机制,以
改善脑缺血再灌流的作用。钙
通道阻滞剂,血管扩张剂等,皮质类固醇,
己酮可可碱和酮丝氨酸可改善微血管
其他组织的缺血,但其机制和有效性
在周围神经中的作用尚不清楚。由于脑缺血的时程
纤维损伤是非常缓慢的,发生在许多小时,神经
包括一个特别适合介入治疗的系统
如果它可用的话。最后,神经儿茶酚胺,
将测定腓肠神经中的二十碳化合物、丙二醛和超氧化物歧化酶。
出于与此无关的原因进行活组织检查,以应用一些
这些技术和策略对人类来说。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PHILLIP A LOW其他文献
PHILLIP A LOW的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PHILLIP A LOW', 18)}}的其他基金
Phase 1 Study of Autologous Mesenchymal Stem Cell in Multiple System Atrophy
自体间充质干细胞治疗多系统萎缩的一期研究
- 批准号:
8925780 - 财政年份:2014
- 资助金额:
$ 17.6万 - 项目类别:
project 4 - Autonomic Rare Diseases Clinical Research Consortium
项目 4 - 自主神经罕见疾病临床研究联盟
- 批准号:
7901214 - 财政年份:2009
- 资助金额:
$ 17.6万 - 项目类别:
Orthostatic Intolerance in Autonomic Neuropathies & Postural Tachycardia Syndrome
自主神经病的直立不耐受
- 批准号:
7640795 - 财政年份:2008
- 资助金额:
$ 17.6万 - 项目类别:
Orthostatic Intolerance in Autonomic Neuropathies & Postural Tachycardia Syndrome
自主神经病的直立不耐受
- 批准号:
6901514 - 财政年份:2005
- 资助金额:
$ 17.6万 - 项目类别:
PATIENTS WITH MULTIPLE SYSTEM ATROPHY, PARKINSON'S DISEASE
多系统萎缩、帕金森病患者
- 批准号:
7206153 - 财政年份:2005
- 资助金额:
$ 17.6万 - 项目类别:
DEVELOPMENT OF TESTS OF AUTONOMIC FUNCTION, LABORATORY EVALUATION
自主功能测试、实验室评估的发展
- 批准号:
7206062 - 财政年份:2005
- 资助金额:
$ 17.6万 - 项目类别:
PATHOPHYSIOLOGY OF ORTHOSTATIC INTOLERANCE USING MSNA
使用 MSNA 进行直立不耐受的病理生理学
- 批准号:
7206091 - 财政年份:2005
- 资助金额:
$ 17.6万 - 项目类别:
PHARMACOLOGIC DISSECTION OF BP CONTROL IN MSA, PD AND PD_AF: EFFECT OF GANGLION
MSA、PD 和 PD_AF 中血压控制的药理学剖析:神经节的作用
- 批准号:
7206138 - 财政年份:2005
- 资助金额:
$ 17.6万 - 项目类别:
相似海外基金
An atypical microtubule generation mechanism for neurons drives dendrite and axon development and regeneration
神经元的非典型微管生成机制驱动树突和轴突的发育和再生
- 批准号:
23K21316 - 财政年份:2024
- 资助金额:
$ 17.6万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Characterizing Wnt Signaling Pathways in Axon Guidance
轴突引导中 Wnt 信号通路的特征
- 批准号:
10815443 - 财政年份:2023
- 资助金额:
$ 17.6万 - 项目类别:
2023 NINDS Landis Mentorship Award - Administrative Supplement to NS121106 Control of Axon Initial Segment in Epilepsy
2023 年 NINDS 兰迪斯指导奖 - NS121106 癫痫轴突初始段控制的行政补充
- 批准号:
10896844 - 财政年份:2023
- 资助金额:
$ 17.6万 - 项目类别:
Does phosphorylation regulation of the axon initial segment cytoskeleton improve behavioral abnormalities in ADHD-like animal models?
轴突起始段细胞骨架的磷酸化调节是否可以改善 ADHD 样动物模型的行为异常?
- 批准号:
23KJ1485 - 财政年份:2023
- 资助金额:
$ 17.6万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Collaborative Research: Evolution of ligand-dependent Robo receptor activation mechanisms for axon guidance
合作研究:用于轴突引导的配体依赖性 Robo 受体激活机制的进化
- 批准号:
2247939 - 财政年份:2023
- 资助金额:
$ 17.6万 - 项目类别:
Standard Grant
Loss-of-function variants of the axon death protein SARM1 and protection from human neurodegenerative disease
轴突死亡蛋白 SARM1 的功能丧失变体和对人类神经退行性疾病的保护
- 批准号:
2891744 - 财政年份:2023
- 资助金额:
$ 17.6万 - 项目类别:
Studentship
Understanding the degeneration of axon and nerve terminals in Alzheimer's disease and related dementia brain
了解阿尔茨海默病和相关痴呆大脑中轴突和神经末梢的变性
- 批准号:
10661457 - 财政年份:2023
- 资助金额:
$ 17.6万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10587090 - 财政年份:2023
- 资助金额:
$ 17.6万 - 项目类别:
Unlocking BIN1 function in oligodendrocytes and support of axon integrity
解锁少突胶质细胞中的 BIN1 功能并支持轴突完整性
- 批准号:
10901005 - 财政年份:2023
- 资助金额:
$ 17.6万 - 项目类别:
The role of RNA methylation in cytoskeleton regulation during axon development
RNA甲基化在轴突发育过程中细胞骨架调节中的作用
- 批准号:
22KF0399 - 财政年份:2023
- 资助金额:
$ 17.6万 - 项目类别:
Grant-in-Aid for JSPS Fellows